Citation 61549

TANAKA,N: OKABE,T: TANAKA,N: TAKE,Y: INOUYE,Y: NAKAMURA,S: NAKASHIMA,H: YAMAMOTO,N:. (1986). INHIBITION BY SAKYOMICIN A OF AVIAN MYELOBLASTOSIS VIRUS REVERSE TRANSCRIPTASE AND PROLIFERATION OF AIDS-ASSOCIATED VIRUS (HTLV-III/LAV).. 77()

Citation Details

TitleINHIBITION BY SAKYOMICIN A OF AVIAN MYELOBLASTOSIS VIRUS REVERSE TRANSCRIPTASE AND PROLIFERATION OF AIDS-ASSOCIATED VIRUS (HTLV-III/LAV).
AuthorsTANAKA,N: OKABE,T: TANAKA,N: TAKE,Y: INOUYE,Y: NAKAMURA,S: NAKASHIMA,H: YAMAMOTO,N:
Year1986
Volume77
Issue

Summary

Year: 1986

Journal: Unknown

Organisms and Their Experiments (1)

Nocardia species (NOCARDIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
ISOLATION AND IDENTIFICATION OF
SAKYOMICIN A
None
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SAKYOMICIN A
ACTIVE
3
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
SAKYOMICIN A
.
4
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SAKYOMICIN A
ACTIVE
5
DNA POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SAKYOMICIN A
INACTIVE
6
DNA POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SAKYOMICIN A
INACTIVE
7
RNA POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SAKYOMICIN A
INACTIVE
8
VIRUS INDUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SAKYOMICIN A
ACTIVE
9
VIRUS FOCUS FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SAKYOMICIN A
WEAK ACTIVITY
10
VIRUS FOCUS FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SAKYOMICIN A
WEAK ACTIVITY
11
VIRUS FOCUS FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SAKYOMICIN A
ACTIVE
12
VIRUS FOCUS FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SAKYOMICIN A
STRONG ACTIVITY
Show SPARQL Queries (1)